Eidelman Virant Capital’s Bristol-Myers Squibb BMY Stock Holding History

Eidelman Virant Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.97M	Hold	41,275	–	–	2.18%	7
2022 Q2	$3.04M	Sell	41,275 -2,700	-6%	-$206K	2.19%	6
2022 Q1	$3.21M	Sell	43,975 -36,770	-46%	-$2.47M	1.73%	12
2021 Q4	$5.05M	Sell	80,745 -1,065	-1%	-$62.5K	1.83%	10
2021 Q3	$4.9M	Sell	81,810 -925	-1%	-$60.9K	1.88%	9
2021 Q2	$5.54M	Sell	82,735 -12,195	-13%	-$795K	2.13%	10
2021 Q1	$6.01M	Buy	94,930 +87,210	+1,130%	+$5.43M	2.42%	9
2020 Q4	$479K	Sell	7,720 -1,700	-18%	-$105K	0.21%	92
2020 Q3	$567K	Sell	9,420 -1,650	-15%	-$99.3K	0.31%	64
2020 Q2	$651K	Buy	+11,070	New	+$662K	0.46%	48

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eidelman Virant Capital's BMY Position: Q3 2022 in Review

Eidelman Virant Capital held its Bristol-Myers Squibb (BMY) position steady in Q3 2022 at 41,275 shares worth $2.97M. The position accounts for 2.18% of the portfolio, ranked #7.

Eidelman Virant Capital first reported a position in BMY in Q2 2020 and has held it in 10 quarters since. The position peaked at $6.01M in Q1 2021. 2,470 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Eidelman Virant Capital held 41,275 shares of Bristol-Myers Squibb worth $2.97M as of Q3 2022.
Eidelman Virant Capital left its Bristol-Myers Squibb share count unchanged in Q3 2022.
Bristol-Myers Squibb made up 2.18% of Eidelman Virant Capital's portfolio in Q3 2022, its #7 holding.
Eidelman Virant Capital first reported a position in Bristol-Myers Squibb in Q2 2020 and has held it in 10 quarters since.
Eidelman Virant Capital's Bristol-Myers Squibb position peaked at $6.01M in Q1 2021.
2,470 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.